Clinical Trial Update: Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety study of BMS-986165 in healthy subjects and in patients with psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BMS-986165

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Healthy Subjects | Phase 1 | Status: COMPLETED